{"transactions":[{"id":941920,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-09T16:38:00.000Z","date":"2026-01-07","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 50,000 restricted stock units on January 7, 2026, which shall vest in full on December 1, 2026, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":73082,"source":{"system":"sec-edgar","filing":"0001104659-26-002509","document":"tm262627-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000110465926002509/tm262627-5_4seq1.xml","form_type":"4"}},{"id":1303264,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-14T17:34:08.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) January 10, 2026 (the first anniversary of the date of grant) or (y) the business day prior to the 2026 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":18500,"derivative":{"exercise_price":0.9525,"expiration_date":"2035-01-10","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001104659-25-003499","document":"tm253166-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000110465925003499/tm253166-6_4seq1.xml","form_type":"4"}},{"id":1303263,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-14T17:34:08.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 12,500 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":23082,"source":{"system":"sec-edgar","filing":"0001104659-25-003499","document":"tm253166-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000110465925003499/tm253166-6_4seq1.xml","form_type":"4"}},{"id":1670742,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-25T06:03:57.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) January 22, 2025 (the first anniversary of the date of grant) or (y) the business day prior to the 2025 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":10000,"derivative":{"exercise_price":0.5195,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-24-006407","document":"tm243935-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000110465924006407/tm243935-4_4seq1.xml","form_type":"4"}},{"id":1670741,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T06:03:57.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 6,000 restricted stock units on January 22, 2024, which shall vest in full on December 1, 2024, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":10582,"source":{"system":"sec-edgar","filing":"0001104659-24-006407","document":"tm243935-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000110465924006407/tm243935-4_4seq1.xml","form_type":"4"}},{"id":2032501,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T17:11:05.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) February 2, 2024 (the first anniversary of the date of grant) or (y) the business day prior to the 2024 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":9500,"derivative":{"exercise_price":3.34,"expiration_date":"2033-02-02","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001104659-23-010619","document":"tm235353d2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000110465923010619/tm235353d2_4seq1.xml","form_type":"4"}},{"id":2032500,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-03T17:11:05.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 2,500 restricted stock units on February 2, 2023, which shall vest in full on December 1, 2023, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":4582,"source":{"system":"sec-edgar","filing":"0001104659-23-010619","document":"tm235353d2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000110465923010619/tm235353d2_4seq1.xml","form_type":"4"}},{"id":2418962,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-01T17:05:46.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":7125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) January 31, 2023 (the first anniversary of the date of grant) or (y) the business day prior to the 2023 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":7125,"derivative":{"exercise_price":5.34,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":7125},"source":{"system":"sec-edgar","filing":"0001104659-22-010393","document":"tm225088-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000110465922010393/tm225088-2_4seq1.xml","form_type":"4"}},{"id":2418961,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-01T17:05:46.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":1900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 1,900 restricted stock units on January 31, 2022, which shall vest in full on December 1, 2022, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":2082,"source":{"system":"sec-edgar","filing":"0001104659-22-010393","document":"tm225088-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000110465922010393/tm225088-2_4seq1.xml","form_type":"4"}},{"id":2802757,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-08T16:30:02.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will fully vest on the earlier of (x) March 4, 2022 (the first anniversary of the date of grant) or (y) the business day prior to the 2022 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":7500,"derivative":{"exercise_price":8,"expiration_date":"2031-03-04","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-21-033301","document":"tm218923d7_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000110465921033301/tm218923d7_4.xml","form_type":"4"}},{"id":3208424,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-16T21:18:18.000Z","date":"2020-03-12","kind":"grant","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will fully vest on the earlier of (x) March 12, 2021 (the first anniversary of the date of grant) or (y) the business day prior to the 2021 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":6500,"derivative":{"exercise_price":1.89,"expiration_date":"2030-03-12","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001104659-20-034285","document":"tm2012902-2_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000110465920034285/tm2012902-2_form4.xml","form_type":"4"}},{"id":3462165,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2019-07-15T09:02:21.000Z","date":"2019-07-11","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options become exercisable in 12 monthly installments, commencing one month from the grant date."}],"balance_after":25000,"derivative":{"exercise_price":5.74,"expiration_date":"2029-07-11","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001562180-19-003935","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/835887/000156218019003935/primarydocument.xml","form_type":"4"}},{"id":3469581,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2019-07-03T08:56:13.000Z","date":"2019-07-01","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":5.33,"exercise_date":"2009-07-01","expiration_date":"2019-07-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-19-003828","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/835887/000156218019003828/primarydocument.xml","form_type":"4"}},{"id":3469580,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-03T08:56:13.000Z","date":"2019-07-01","kind":"exercise","acquired":true,"shares":10000,"price":5.33,"value":53300.0,"ownership":{"direct":true},"balance_after":56185,"source":{"system":"sec-edgar","filing":"0001562180-19-003828","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/835887/000156218019003828/primarydocument.xml","form_type":"4"}},{"id":3590189,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-18T19:04:32.000Z","date":"2019-03-14","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will fully vest on the earlier of (x) March 14, 2020 (the first anniversary of the date of grant) or (y) the day prior to the 2020 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":25000,"derivative":{"exercise_price":1.38,"expiration_date":"2029-03-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-19-008207","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000089924319008207/doc4.xml","form_type":"4"}},{"id":3894765,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-06-14T14:37:50.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes exercisable immediately on the date of grant."}],"balance_after":25000,"derivative":{"exercise_price":8.99,"exercise_date":"2018-06-13","expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001562180-18-002997","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/835887/000156218018002997/primarydocument.xml","form_type":"4"}},{"id":3895175,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-13T18:34:23.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will fully vest on the earlier of (x) June 12, 2019 (the first anniversary of the date of grant) or (y) the day prior to the 2019 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":5500,"derivative":{"exercise_price":5.23,"expiration_date":"2028-06-11","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001209191-18-037555","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000120919118037555/doc4.xml","form_type":"4"}},{"id":3992020,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-16T16:31:43.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":9107,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the merger of SELLAS Life Sciences Group, Ltd (\"SELLAS\") and a wholly owned indirect subsidiary of the Issuer (then known as Galena Biopharma, Inc.) (the \"Merger\"), outstanding restricted stock units (\"RSUs\") to be settled in SELLAS common shares were assumed by the Issuer and will be settled in shares of the Issuer's common stock based on the following exchange ratio: 43.9972 shares of the Issuer's common stock for each common share of SELLAS."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares issuable upon vesting of RSUs. The RSUs are subject to, and to vest must satisfy, both (a) performance-based vesting restrictions (the RSUs will satisfy the performance-based vesting restrictions upon a liquidity event as defined in the award agreement) and (b) time-based vesting restrictions (100% of the RSUs satisfied the time-based vesting restrictions on February 27, 2018). The Merger did not constitute a liquidity event for the performance-based vesting restrictions."}],"balance_after":9107,"source":{"system":"sec-edgar","filing":"0001209191-18-020187","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000120919118020187/doc4a.xml","form_type":"4/A","original_submission_date":"2017-12-29"}},{"id":3994378,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-15T20:00:42.000Z","date":"2018-03-13","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares will vest and became exercisable in equal monthly installments for thirty-six (36) months following the March 13, 2018 grant date, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":11000,"derivative":{"exercise_price":5.24,"expiration_date":"2028-03-12","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-18-020018","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000120919118020018/doc4.xml","form_type":"4"}},{"id":4118874,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-29T17:11:19.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":9107,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the merger of SELLAS Life Sciences Group, Ltd (\"SELLAS\") and a wholly owned indirect subsidiary of the Issuer (then known as Galena Biopharma, Inc.) (the \"Merger\"), outstanding restricted stock units (\"RSUs\") to be settled in SELLAS common shares were assumed by the Issuer and will be settled in shares of the Issuer's common stock based on the following exchange ratio: 43.9972 shares of the Issuer's common stock for each common share of SELLAS."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares issuable upon vesting of RSUs.  100% of the shares subject to the RSUs will vest on February 27, 2018."}],"balance_after":9107,"source":{"system":"sec-edgar","filing":"0001209191-17-067659","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000120919117067659/doc4.xml","form_type":"4"}},{"id":4281717,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2017-06-15T15:09:02.000Z","date":"2017-06-14","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes exercisable immediately, on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":6.95,"exercise_date":"2017-06-14","expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-17-002268","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/835887/000156218017002268/primarydocument.xml","form_type":"4"}}]}